Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials

Respir Med. 2021 Sep:186:106535. doi: 10.1016/j.rmed.2021.106535. Epub 2021 Jul 6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Clinical Trials as Topic*
  • Humans
  • Medical Oncology*
  • Practice Guidelines as Topic
  • Risk Factors
  • Severity of Illness Index

Substances

  • COVID-19 Vaccines